India administers over 200 mn Covid-19 vaccine doses till May 25

In a landmark achievement in its fight against Covid-19, India has cumulatively administered more than 200 million vaccine doses up till 7 pm on May 25

vaccination, coronavirus, covid-19, vaccines
ANI General News
2 min read Last Updated : May 26 2021 | 7:17 AM IST

In a landmark achievement in its fight against COVID-19, India has cumulatively administered more than 20 crore vaccine doses up till 7 pm on May 25.

As many as 20,04,94,991 vaccine jabs have been administered as of May 25.

"India has crossed a significant landmark in its fight against COVID-19 pandemic. The country has administered more than 20 crore (20,04,94,991) vaccine doses as per the 7 pm provisional report. Vaccination is an integral pillar of the comprehensive strategy of government of India for containment and management of the pandemic, along with Test, Track, Treat and COVID Appropriate Behaviour," read an official statement by the Centre.

A total of 9,42,796 beneficiaries of the age group 18-44 years have received their first dose of COVID-19 vaccine on Tuesday and cumulatively 1,28,74,546 doses across 37 states and union territories (UTs) since the start of Phase-3 of the vaccination drive.

Bihar, Rajasthan, and Uttar Pradesh have administered more than 10 lakh beneficiaries of the age group 18-44 years for their first dose of COVID vaccine.

The total of 20,04,94,991 jabs include 97,94,835 Healthcare Workers (HCWs) who have taken the first dose and 67,28,443 HCWs who have taken the second dose, 1,51,62,077 Frontline Workers (FLWs) with their first doses, 83,77,270 FLWs with their both jabs.

The total also includes 1,28,74,546 first doses for 18-44 years of age group. 6,20,47,952 first doses for over 45 years old to 60 years old, 1,00,24,157 second doses for over 45 years old to 60 years old, 5,71,19,900 first jabs for above 60 years and 1,83,65,811 second jabs for above 60 years.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccine

First Published: May 26 2021 | 7:00 AM IST

Next Story